Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer. by Griffiths, R, Barron, R, Gleeson, M, Danese, MD, O'Hagan, A, Chia, V, Legg, J, Lyman, G

Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with Venous Thromboembolism: Results of a randomized trial (SELECT-D) by Young, A, Marshall, A, Thirlwall, J, Chapman, O, Lokare, A, Hill, C, Hale, D, Dunn, J, Lyman, G, Hutchinson, C, MacCallum, P, Kakkar, A, Hobbs, F, Petrou, S, Dale, J, Poole, C, Maraveyas, A, Levine, M